DICE Therapeutics (DICE) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free DICE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis DICE Therapeutics Short Interest DataCurrent Short Volume4,360,000 sharesPrevious Short Volume4,880,000 sharesChange Vs. Previous Month-10.66%Dollar Volume Sold Short$204.92 millionShort Interest Ratio / Days to Cover2.5Last Record DateJuly 31, 2023Outstanding Shares47,731,000 sharesFloat Size41,850,000 sharesShort Percent of Float10.42%Today's Trading Volume0 sharesAverage Trading Volume1,028,719 sharesToday's Volume Vs. Average0% Short Selling DICE Therapeutics ? Sign up to receive the latest short interest report for DICE Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDICE Short Interest Over TimeDICE Days to Cover Over TimeDICE Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here DICE Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20234,360,000 shares $204.92 million -10.7%10.4%2.5 $47.00 7/15/20234,880,000 shares $227.51 million +13.5%11.7%3.1 $46.62 6/30/20234,300,000 shares $199.78 million -47.0%10.3%2.8 $46.46 6/15/20238,110,000 shares $279.80 million +3.7%20.6%6.4 $34.50 5/31/20237,820,000 shares $247.19 million -2.4%20.3%15.9 $31.61 5/15/20238,010,000 shares $278.27 million -9.0%20.8%15.2 $34.74 Get the Latest News and Ratings for DICE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DICE Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/30/20238,800,000 shares $286 million +3.5%22.9%17 $32.50 4/15/20238,500,000 shares $228.14 million +4.6%22.1%17.1 $26.84 3/31/20238,130,000 shares $232.92 million +18.7%21.2%16.8 $28.65 3/15/20236,850,000 shares $189.27 million +13.2%17.8%14.9 $27.63 2/28/20236,050,000 shares $180.53 million +5.4%19.7%14.2 $29.84 2/15/20235,740,000 shares $172.89 million +5.1%18.7%14.7 $30.12 1/31/20235,460,000 shares $173.46 million +3.4%17.7%14.1 $31.77 1/15/20235,280,000 shares $155.55 million +3.5%17.3%11.5 $29.46 12/30/20225,100,000 shares $159.12 million +16.2%16.7%5.9 $31.20 12/15/20224,390,000 shares $148.60 million -0.2%14.4%5 $33.85 11/30/20224,400,000 shares $153.16 million +1.2%14.5%4.8 $34.81 11/15/20224,350,000 shares $146.29 million -0.2%14.3%4.8 $33.63 10/31/20224,360,000 shares $154.82 million +6.3%14.9%4.9 $35.51 10/15/20224,100,000 shares $153.79 million -19.6%14.1%4.8 $37.51 9/30/20225,100,000 shares $103.43 million +3.5%17.5%12.1 $20.28 9/15/20224,930,000 shares $98.75 million -5.6%16.9%11.7 $20.03 8/31/20225,220,000 shares $81.95 million -7.8%17.9%13.2 $15.70 8/15/20225,660,000 shares $119.03 million -3.9%19.4%14.5 $21.03 7/31/20225,890,000 shares $101.54 million +0.2%20.2%14.5 $17.24 7/15/20225,880,000 shares $93.73 million +2.4%20.1%13.5 $15.94 6/30/20225,740,000 shares $89.08 million +21.1%19.7%13.2 $15.52 6/15/20224,740,000 shares $66.55 million +31.3%16.2%10.6 $14.04 5/31/20223,610,000 shares $49.64 million +13.2%12.4%8.7 $13.75 5/15/20223,190,000 shares $55.76 million +23.2%10.9%8.9 $17.48 4/30/20222,590,000 shares $52.63 million +8.4%8.9%8 $20.32 4/15/20222,390,000 shares $46.94 million +3.5%8.2%7.7 $19.64 3/31/20222,310,000 shares $44.19 million -9.4%7.9%7.7 $19.13 3/15/20222,550,000 shares $43.55 million +17.0%8.7%9.3 $17.08 2/28/20222,180,000 shares $40.31 million +14.1%7.5%6.8 $18.49 2/15/20221,910,000 shares $31.69 million -5.9%6.5%5.7 $16.59 1/31/20222,030,000 shares $34.57 million -12.1%7.0%6.3 $17.03 1/15/20222,310,000 shares $38.95 million -6.5%7.1%7.9 $16.86 12/31/20212,470,000 shares $62.52 million No Change8.4%9.3 $25.31 DICE Short Interest - Frequently Asked Questions What is DICE Therapeutics' current short interest? Short interest is the volume of DICE Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 4,360,000 shares of DICE short. 10.42% of DICE Therapeutics' shares are currently sold short. Learn More on DICE Therapeutics' current short interest. What is a good short interest ratio for DICE Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DICE shares currently have a short interest ratio of 2.0. Learn More on DICE Therapeutics's short interest ratio. What is a good short interest percentage for DICE Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.42% of DICE Therapeutics' floating shares are currently sold short. Is DICE Therapeutics' short interest increasing or decreasing? DICE Therapeutics saw a decrease in short interest in the month of July. As of July 31st, there was short interest totaling 4,360,000 shares, a decrease of 10.7% from the previous total of 4,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is DICE Therapeutics' float size? DICE Therapeutics currently has issued a total of 47,731,000 shares. Some of DICE Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. DICE Therapeutics currently has a public float of 41,850,000 shares. How does DICE Therapeutics' short interest compare to its competitors? 10.42% of DICE Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to DICE Therapeutics: Crinetics Pharmaceuticals, Inc. (7.05%), Bausch Health Companies Inc. (6.31%), Verona Pharma plc (8.12%), Akero Therapeutics, Inc. (11.34%), Centessa Pharmaceuticals plc (3.08%), Scholar Rock Holding Co. (16.08%), RayzeBio, Inc. (2.32%), Icosavax, Inc. (0.99%), Gracell Biotechnologies Inc. (1.64%), ALX Oncology Holdings Inc. (11.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.34 billion), Occidental Petroleum Co. ($2.88 billion), Coinbase Global, Inc. ($2.50 billion), Rivian Automotive, Inc. ($2.47 billion), Palantir Technologies Inc. ($2.37 billion), Royal Caribbean Cruises Ltd. ($2.33 billion), T. Rowe Price Group, Inc. ($2.29 billion), Tractor Supply ($1.59 billion), Upstart Holdings, Inc. ($1.58 billion), and Enphase Energy, Inc. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short DICE Therapeutics stock? Short selling DICE is an investing strategy that aims to generate trading profit from DICE Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against DICE Therapeutics? A short squeeze for DICE Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DICE, which in turn drives the price of the stock up even further. How often is DICE Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DICE, twice per month. The most recent reporting period available is July, 31 2023. More Short Interest Resources from MarketBeat Related Companies: CRNX Short Squeeze BHC Short Squeeze VRNA Short Squeeze AKRO Short Squeeze CNTA Short Squeeze SRRK Short Squeeze RYZB Short Squeeze ICVX Short Squeeze GRCL Short Squeeze ALXO Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DICE) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldPentagon contract could send this $2 AI stock soaringBehind the Markets